Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole
- 31 March 2010
- journal article
- other
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 35 (3), 311-312
- https://doi.org/10.1016/j.ijantimicag.2009.11.008
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe RefractoryClostridium difficileInfectionClinical Infectious Diseases, 2009
- Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078Clinical Infectious Diseases, 2008
- The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfectionClinical Infectious Diseases, 2008
- Outcomes of Clostridium difficile-Associated Disease Treated With Metronidazole or Vancomycin Before and After the Emergence of NAP1/027The American Journal of Gastroenterology, 2007
- In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004Antimicrobial Agents and Chemotherapy, 2007
- Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric DiseaseAnnals of Internal Medicine, 2006
- Clostridium difficileInfection in Patients Discharged from US Short-stay Hospitals, 1996–20031Emerging Infectious Diseases, 2006